HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45649,
"recordsTotal": 45649,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&start=45600",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&start=45000",
"results": [
{
"registry_id": "NCT06179472",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06179472",
"title": "Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, a Phase III Trial",
"has_exemption": false,
"start_date": "2024-04-14",
"completion_date": "2031-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Mercy Hospital Kansas City",
"sponsor_slug": "childrens-mercy-hospital-kansas-city",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07082842",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07082842",
"title": "A Multicenter, Parallel, Randomized, Placebo (Double-blind) and Pirfenidone (Open-label) Controlled Phase III Clinical Trial Evaluating the Efficacy and Safety of HEC585 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)",
"has_exemption": false,
"start_date": "2025-10-09",
"completion_date": "2031-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Sunshine Lake Pharma Co., Ltd.",
"sponsor_slug": "sunshine-lake-pharma-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06615050",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06615050",
"title": "A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2025-04-02",
"completion_date": "2031-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06609239",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06609239",
"title": "An Open Label Extension Study to Evaluate the Long-term Safety and Efficacy of Subcutaneous Lunsekimig in Adult Participants With Moderatetosevere Asthma Who Participated in Study DRI16762",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2031-01-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03725059",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03725059",
"title": "A Randomized, Double-Blind, Phase III Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (KEYNOTE-756)",
"has_exemption": false,
"start_date": "2018-12-27",
"completion_date": "2031-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06667700",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06667700",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2031-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06914908",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06914908",
"title": "A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2031-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03076658",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03076658",
"title": "Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers",
"has_exemption": false,
"start_date": "2016-09-30",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06185205",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06185205",
"title": "Accelerated Super-Hypofractionated Breast Brachytherapy - ASHBY Trial",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06313203",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06313203",
"title": "Trans-arterial Treatment of Patients with Intra-hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oslo University Hospital",
"sponsor_slug": "oslo-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765902",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06765902",
"title": "Open-Label, Phase 2 Clinical Trial of Pre-Surgery and Post-Surgery Immunotherapy With N-803, ETBX-071, and M-CENK in Combination With Surgery for Participants With High-Risk Prostate Cancer Pre-Prostatectomy.",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765954",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06765954",
"title": "Open-Label, Phase 2 Clinical Trial of Pre-Radiation and Post-Radiation Immunotherapy With N-803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06361810",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06361810",
"title": "A Phase 1/2 Open-label Study of Pembrolizumab Combined With PNT-2002 Radioligand Therapy in Patients With Metastatic Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07059091",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07059091",
"title": "Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (COPD-OMA)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06543576",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06543576",
"title": "A Prospective Cohort Study of Integrating Radiotherapy Into Chemotherapy With Pembrolizumab and Bevacizumab in Newly Diagnosed Stage IVB Cervical Cancer",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06312722",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06312722",
"title": "Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study",
"has_exemption": false,
"start_date": "2024-02-07",
"completion_date": "2031-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Urotronic Inc.",
"sponsor_slug": "urotronic-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06401330",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06401330",
"title": "Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2031-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780111",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06780111",
"title": "A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2031-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06302348",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06302348",
"title": "A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin",
"has_exemption": false,
"start_date": "2024-03-04",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "PTC Therapeutics",
"sponsor_slug": "ptc-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544798",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06544798",
"title": "Long-term Follow-up of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia",
"has_exemption": false,
"start_date": "2024-08-02",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx, LLC",
"sponsor_slug": "meiragtx-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06803771",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06803771",
"title": "A Randomised Trial to Evaluate the CfDNA Pancreatic Cancer Test (Avantect) in the Early Detection of Pancreatic Cancer in Patients with Newly Diagnosed Diabetes Mellitus",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital Southampton NHS Foundation Trust",
"sponsor_slug": "university-hospital-southampton-nhs-foundation-trust",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799195",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06799195",
"title": "A Phase II Randomized Trial to Optimize GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation in Older Adults With Hematological Malignancies: the PROMISE Trial",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2031-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05626114",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05626114",
"title": "A Phase IIa, Multicenter, Open-Label, Single-Arm Study To Optimize Subretinal Surgical Delivery And To Evaluate Safety And Activity Of Opregen In Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2031-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06912763",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06912763",
"title": "Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)",
"has_exemption": false,
"start_date": "2025-09-18",
"completion_date": "2031-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042140",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06042140",
"title": "Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair: Single Arm Phase III Trial.",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2031-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05538091",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05538091",
"title": "Phase II Clinical Trial Combining the Hedgehog Inhibitor Vismodegib With the PD-L1 Inhibitor Atezolizumab in Patients With Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2031-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Ronald Buckanovich",
"sponsor_slug": "ronald-buckanovich",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06616597",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06616597",
"title": "Phase II Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2031-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05064540",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05064540",
"title": "JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Endologix",
"sponsor_slug": "endologix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05235165",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05235165",
"title": "A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05605899",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05605899",
"title": "An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel Versus Standard of Care Therapy as First-Line Therapy in Subjects With High-Risk Large B-Cell Lymphoma (ZUMA-23)",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007677",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06007677",
"title": "A Phase 2 Long-Term Open-Label Trial to Assess the Safety and Efficacy of Repeat Dosing of STAR-0215 in Adult Patients With Hereditary Angioedema (The ALPHA-SOLAR Trial)",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astria Therapeutics, Inc.",
"sponsor_slug": "astria-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810505",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06810505",
"title": "A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Chronic Migraine in Pediatric Subjects 12 to 17 Years of Age",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839456",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06839456",
"title": "Phase 1/2 Study: CD45RA Depleted Peripheral Stem Cell Addback to Prevent Viral and Fungal Infections Following Alternative Donor TCRab/CD19 Depleted Hematopoietic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907875",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06907875",
"title": "A Phase 1/2 Open-label Dose-escalation Study to Evaluate the Safety, Tolerability, and Biological Activity of EPI-321, an AAVrh74-delivered Epigenetic Editing Therapy in Adult FSHD Patients",
"has_exemption": false,
"start_date": "2025-05-08",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Epicrispr Biotechnologies, Inc.",
"sponsor_slug": "epicrispr-biotechnologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05972629",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05972629",
"title": "A Phase 1/Phase 2, Open-label, Dose-escalation, and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of SAR444836, an Adeno-associated Viral Vector-mediated Gene Transfer of Human Phenylalanine Hydroxylase, in Adult Participants With Phenylketonuria",
"has_exemption": false,
"start_date": "2023-08-07",
"completion_date": "2031-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06785415",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06785415",
"title": "Phase 1/2 Trial of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2031-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408259",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06408259",
"title": "A Phase 3, Multicenter, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2031-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05788536",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05788536",
"title": "A PHASE 1/2, OPEN-LABEL, MULTICENTER TRIAL WITH A SINGLE ASCENDING DOSE COHORT WITH UNILATERAL INTRACOCHLEAR INJECTION FOLLOWED BY A BILATERAL INJECTION EXPANSION COHORT TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF DB-OTO IN CHILDREN AND INFANTS WITH BIALLELIC hOTOF MUTATIONS",
"has_exemption": false,
"start_date": "2023-06-27",
"completion_date": "2031-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06912698",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06912698",
"title": "A Phase III Randomized Controlled Non-Inferiority Clinical Trial Comparing Reduced-Dose Versus Standard-Dose Radiotherapy Based on Treatment Response in Early-Stage Nasopharyngeal Carcinoma",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2031-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Hai-Qiang Mai,MD,PhD",
"sponsor_slug": "hai-qiang-maimdphd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05367440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05367440",
"title": "A Multi-arm, Open-label Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of AZD5305 in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)",
"has_exemption": false,
"start_date": "2022-06-02",
"completion_date": "2031-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564038",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06564038",
"title": "A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination With Other Anticancer Agents in Participants With Mature B-Cell Malignancies",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2031-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05675410",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05675410",
"title": "A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2031-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05552222",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05552222",
"title": "A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy",
"has_exemption": false,
"start_date": "2022-10-25",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07021937",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07021937",
"title": "Investigating Brain PLASTICity and GLP-1 Receptor Agonists in the Treatment of Obesity: The PLASTIC Trial",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964230",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06964230",
"title": "A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-10-26",
"completion_date": "2031-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "T3D Therapeutics, Inc.",
"sponsor_slug": "t3d-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05991388",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05991388",
"title": "A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2024-05-02",
"completion_date": "2031-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Birmingham",
"sponsor_slug": "university-of-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03033992",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03033992",
"title": "Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma or Ependymoma, and Feasibility and Efficacy Trial of Optune in Conjunction With Radiation Therapy for Children With Newly Diagnosed DIPG",
"has_exemption": false,
"start_date": "2017-04-04",
"completion_date": "2031-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Brain Tumor Consortium",
"sponsor_slug": "pediatric-brain-tumor-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06710626",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06710626",
"title": "CONVOY: An Early Feasibility Study of Neural Control of Assistive Devices Via Brain-Computer Interface Technology",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2031-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuralink Corp",
"sponsor_slug": "neuralink-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05561387",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05561387",
"title": "A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of \"Intermediate Fit\" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919003",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06919003",
"title": "Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (RTB-021)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2031-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03314181",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03314181",
"title": "A Phase 1/2, Multicenter, Dose-Escalation and Expansion Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Subjects With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2018-04-02",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05856370",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05856370",
"title": "The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2031-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Spinal and Biologics",
"sponsor_slug": "medtronic-spinal-and-biologics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02375204",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02375204",
"title": "A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) As First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors",
"has_exemption": false,
"start_date": "2015-08-06",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06967610",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06967610",
"title": "Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2031-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04657822",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04657822",
"title": "An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2031-06-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02065011",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02065011",
"title": "An Open-label Study to Determine the Long-term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B",
"has_exemption": false,
"start_date": "2013-09-12",
"completion_date": "2031-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06482684",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06482684",
"title": "Early Treatment Intensification in Patients With High Risk Mantle Cell Lymphoma Using CAR-T-cell Treatment After an Abbreviated Induction Therapy With Rituximab and Ibrutinib and 6 Months Ibrutinib Maintenance (Arm A) as Compared to Standard of Care Induction and Maintenance (Arm B)",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2031-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Christian Schmidt, MD",
"sponsor_slug": "christian-schmidt-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02919592",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02919592",
"title": "MemoryShape® and MemoryGel® Breast Implants Post Approval New Enrollment Study (\"Glow Study\")",
"has_exemption": false,
"start_date": "2016-09-01",
"completion_date": "2031-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Mentor Worldwide, LLC",
"sponsor_slug": "mentor-worldwide-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06363994",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06363994",
"title": "A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 Study of Orelabrutinib in Combination with Rituximab and Bendamustine (BR) Vs. BR in Subjects with Treatment-Naїve Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-05-29",
"completion_date": "2031-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "InnoCare Pharma Inc.",
"sponsor_slug": "innocare-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858319",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06858319",
"title": "A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2031-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03424018",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03424018",
"title": "A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2017-12-12",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04923126",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04923126",
"title": "SJ901: Phase 1/2 Evaluation of Single Agent Mirdametinib (PD-0325901), a Brain-Penetrant MEK1/2 Inhibitor, for the Treatment of Children, Adolescents, and Young Adults With Low-Grade Glioma",
"has_exemption": false,
"start_date": "2021-06-21",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06278870",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06278870",
"title": "Disitamab Vedotin in Combination With Pyrotinib Versus THP in the First-line Treatment for HER2-positive Advanced Breast Cancer, a Multicentre, Randomized, Double-blind Controlled, Phase III Trial",
"has_exemption": false,
"start_date": "2023-09-06",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
"sponsor_slug": "sun-yat-sen-memorial-hospital-of-sun-yat-sen-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04990921",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04990921",
"title": "A Phase 2 Study of Palliative Radiation in Combination with Pembrolizumab in Subjects with Unresectable Metastatic Stage IV Breast Cancer: Twisted Pink",
"has_exemption": false,
"start_date": "2021-09-02",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026942",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07026942",
"title": "A Phase I/II Clinical Trial Evaluating the Safety and Efficacy of Universal Donor CD33 CAR Natural Killer Cells for Treatment of Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544616",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06544616",
"title": "A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-64042056, a Phosphorylated Tau Targeted Active Immunotherapy, in Participants With Preclinical Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-07-22",
"completion_date": "2031-07-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Pharmaceutica N.V., Belgium",
"sponsor_slug": "janssen-pharmaceutica-nv-belgium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06538337",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06538337",
"title": "Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers (HERA Trial)",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2031-07-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03773965",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03773965",
"title": "A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)",
"has_exemption": false,
"start_date": "2019-04-05",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05905926",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05905926",
"title": "An Open-Label Long-Term Safety Study of Tenapanor for the Treatment of Irritable Bowel Syndrome With Constipation (IBS-C) in Pediatric Patients 6 to Less Than 18 Years Old",
"has_exemption": false,
"start_date": "2023-02-17",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ardelyx",
"sponsor_slug": "ardelyx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05907746",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05907746",
"title": "A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789913",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06789913",
"title": "A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Relay Therapeutics, Inc.",
"sponsor_slug": "relay-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899152",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06899152",
"title": "HepQuant: Pilot Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991101",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06991101",
"title": "Randomized Phase 2 Trial of Ruxolitinib in Combination With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma.",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948786",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06948786",
"title": "PROMOTE-FL: Pirtobrutinib and Mosunetuzumab to Enhance Treatment Efficacy for Patients With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990737",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06990737",
"title": "Phase 2 Pragmatic Trial Investigating Sentinel Lymph Node Biopsy (SLNB) Efficacy and Safety in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck",
"has_exemption": false,
"start_date": "2025-06-25",
"completion_date": "2031-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521814",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06521814",
"title": "Globus Reflect Tether - Humanitarian Use Device",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2031-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07063745",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07063745",
"title": "A Randomized Phase 2/3 Study of BMS-986504 in Combination With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion",
"has_exemption": false,
"start_date": "2025-10-06",
"completion_date": "2031-08-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568172",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06568172",
"title": "Randomized Phase III Trial of Perioperative Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-02-18",
"completion_date": "2031-08-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05442567",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05442567",
"title": "A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2031-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940297",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06940297",
"title": "DART: Phase II Study of Dasatinib and Quercetin in Patients With Relapsed, Refractory Multiple Myeloma Receiving CAR-T Therapy",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2031-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06922318",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06922318",
"title": "A Phase II Study of Sequential Bipolar Androgen Therapy and ZEN-3694 in Sequence With Enzalutamide + ZEN-3694 in Asymptomatic Patients With Metastatic CRPC: The COSMYC Trial (COmbined Suppression of MYC)",
"has_exemption": false,
"start_date": "2025-08-30",
"completion_date": "2031-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00969111",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00969111",
"title": "Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy",
"has_exemption": false,
"start_date": "2009-08-31",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04933721",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04933721",
"title": "An Open-label Study to Provide Berotralstat Access to Subjects With Type 1 and 2 Hereditary Angioedema Who Were Previously Enrolled in Berotralstat Studies",
"has_exemption": false,
"start_date": "2021-07-23",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioCryst Pharmaceuticals",
"sponsor_slug": "biocryst-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06441006",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06441006",
"title": "Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis (PRISM-TB)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05155033",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05155033",
"title": "Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2022-08-18",
"completion_date": "2031-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06188741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06188741",
"title": "Phase 2 Trial of Selumetinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Neurofibromatosis Type 1",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2031-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866262",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06866262",
"title": "Phase I/II Trial of Inulin Gel in Combination With Ipilimumab and Nivolumab in Advanced Renal Cell Carcinoma [ICON Trial]",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2031-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833073",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06833073",
"title": "A Phase 2 Open-label Randomized Study of V940 in Combination With BCG Versus BCG Monotherapy in Participants With High-risk Non-muscle Invasive Bladder Cancer (INTerpath-011)",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2031-09-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06247995",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06247995",
"title": "A Phase I/II, Open-label, Multi-center Trial of [177Lu]Lu-NeoB in Combination With Capecitabine in Adult Patients With Gastrin Releasing Peptide Receptor Positive, Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor-2 Negative Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.",
"has_exemption": false,
"start_date": "2024-08-14",
"completion_date": "2031-09-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04245839",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04245839",
"title": "A Phase 2, Open-label, Single Arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)",
"has_exemption": false,
"start_date": "2020-07-14",
"completion_date": "2031-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934967",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06934967",
"title": "An Open-label, Single-arm, Multicenter, Phase 3 Study to Assess Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric PNH Patients 2 to <18 Years of Age",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2031-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05624996",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05624996",
"title": "Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2023-07-12",
"completion_date": "2031-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06313996",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06313996",
"title": "A Global Randomized Multicenter Phase 3 Trial to Compare the Efficacy and Safety of Lisocabtagene Maraleucel (JCAR017/BMS-986387) to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma (TRANSFORM FL)",
"has_exemption": false,
"start_date": "2024-03-29",
"completion_date": "2031-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049926",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07049926",
"title": "A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (KEYMAKER-U03): Substudy 03C in Participants With Recurrent Disease During or After Anti-PD-(L)1 Adjuvant Therapy",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2031-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236438",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06236438",
"title": "A Randomized, Phase 2/3 Study to Evaluate the Optimal Dose, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2024-04-10",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06188702",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06188702",
"title": "A Phase 1/2, Open-label, Multicenter Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Antineoplastic Activity of S095035 (MAT2A Inhibitor) as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Homozygous Deletion of MTAP",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013423",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06013423",
"title": "Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics",
"has_exemption": false,
"start_date": "2024-07-23",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06898450",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06898450",
"title": "A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of NDI-219216 in Patients With Advanced Solid Tumors With/Without Microsatellite Instability and/or Deficient Mismatch Repair",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nimbus Wadjet, Inc.",
"sponsor_slug": "nimbus-wadjet-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06563895",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06563895",
"title": "A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2031-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788912",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06788912",
"title": "KEYMAKER-U01 Substudy 01E: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2031-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564844",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06564844",
"title": "A Phase III, Randomised, Open-label, Global Study of Adjuvant Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma Non-small Cell Lung Cancer Who Are ctDNA-positive or Have High-risk Pathological Features (TROPION-Lung12)",
"has_exemption": false,
"start_date": "2024-10-15",
"completion_date": "2031-11-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06549595",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06549595",
"title": "A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 Plus Rituximab Versus Chemotherapy Plus Rituximab in Previously Untreated Participants With Follicular Lymphoma (SOUNDTRACK-F1)",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2031-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05156398",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05156398",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age",
"has_exemption": false,
"start_date": "2022-02-28",
"completion_date": "2031-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06969430",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06969430",
"title": "A Phase 1/2, First-in-human, Multicenter, Open-label Trial Evaluating the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07007312",
"title": "Phase 3 Randomized, Double-blind, Placebo-controlled Studies Assessing Ziftomenib in Combination With Either Standard of Care Nonintensive (Venetoclax+Azacitidine) or Intensive (7+3) Therapy in Patients With Untreated NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145010",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05145010",
"title": "Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL OLE",
"has_exemption": false,
"start_date": "2021-12-06",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, Inc.",
"sponsor_slug": "qed-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06663332",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06663332",
"title": "A Phase 3, Multicenter, Open-label, Basket, LTE Study to Evaluate the Safety of Guselkumab in Pediatric Participants With Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2031-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632444",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06632444",
"title": "A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase III Trial Evaluating Long-term Efficacy and Safety of Survodutide Weekly Injections in Adult Participants With Noncirrhotic Non-alcoholic Steatohepatitis/Metabolic Dysfunction-associated Steatohepatitis (NASH/MASH) and (F2) - (F3) Stage of Liver Fibrosis",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2031-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04580420",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04580420",
"title": "A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis",
"has_exemption": false,
"start_date": "2021-04-15",
"completion_date": "2031-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06620302",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06620302",
"title": "DT2216 in Combination With Irinotecan for Children, Adolescents and Young Adults With Relapsed or Refractory Solid Tumors: A Phase I Study With Phase II Feasibility Cohort for Fibrolamellar Carcinoma",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2031-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01524211",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01524211",
"title": "Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms",
"has_exemption": false,
"start_date": "2012-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04586166",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04586166",
"title": "SASS: Randomized Trial of Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for Concomitant Management of Stress Urinary Incontinence During Minimally Invasive Sacrocolpopexy",
"has_exemption": false,
"start_date": "2020-12-23",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04124341",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04124341",
"title": "Prefrontal Cortical Stimulation (PCS) for Severe Treatment Resistant Depression",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05478304",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05478304",
"title": "Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AtriCure, Inc.",
"sponsor_slug": "atricure-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05071937",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05071937",
"title": "Phase ll Study of a BET Inhibitor, ZEN003694, Combined With a PARP Inhibitor, Talazoparib, in Patients With Recurrent Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-04-21",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexander B Olawaiye, MD",
"sponsor_slug": "alexander-b-olawaiye-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06019832",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06019832",
"title": "Analysis of Varus Collapse in Obese Patients With Stem and Non-Stem Tibial Components Following Primary Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jacob M. Elkins",
"sponsor_slug": "jacob-m-elkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134232",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06134232",
"title": "An Open -Label, Multicenter Study of Subjects With Metastatic Castrate-Resistant Prostate Cancer Treated With PROVENGE ® and Boosted With A Single Infusion of Sipuleucel-T to Measure Immune Response",
"has_exemption": false,
"start_date": "2023-11-27",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dendreon",
"sponsor_slug": "dendreon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428721",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06428721",
"title": "The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population",
"has_exemption": false,
"start_date": "2024-03-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wright State University",
"sponsor_slug": "wright-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483100",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06483100",
"title": "Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06390956",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06390956",
"title": "A Phase II Study of Pirtobrutinib in Combination With Rituximab in Newly Diagnosed Marginal Zone Lymphoma: A Risk Adapted Approach",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06529809",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06529809",
"title": "Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951217",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06951217",
"title": "A Multinational, Long-Term, Safety and Tolerability, Open-Label Extension Study of Subjects Who Have Participated in Avalyn Pharma Studies of Inhaled Antifibrotic Agents (AP-LTE-008 [SAIL])",
"has_exemption": false,
"start_date": "2025-04-17",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avalyn Pharma Inc.",
"sponsor_slug": "avalyn-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070115",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07070115",
"title": "A Prospective Study Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® Reinforced Tissue Matrix",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tela Bio Inc",
"sponsor_slug": "tela-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06694454",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06694454",
"title": "Phase I/II Study of Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07001254",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07001254",
"title": "Phase II Open-label Clinical Trial Evaluating Efficacy of Romiplostim Added to Standard of Care for Children and Young Adults With Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Anjali Sharathkumar",
"sponsor_slug": "anjali-sharathkumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07005102",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07005102",
"title": "A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04077099",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04077099",
"title": "A Phase 1/2 Study of REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2020-01-07",
"completion_date": "2032-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05212246",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05212246",
"title": "CSP #2019 - Basal Cell Carcinoma Chemoprevention Trial (B3C)",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2032-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745076",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06745076",
"title": "A Multicenter Study PRECISE-HL: Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation in Advanced Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2032-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06405087",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06405087",
"title": "A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Subcutaneous in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2032-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06770582",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06770582",
"title": "Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial)",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2032-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686121",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06686121",
"title": "IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2032-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013487",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07013487",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Immunogenicity, and Efficacy of V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age",
"has_exemption": false,
"start_date": "2025-06-11",
"completion_date": "2032-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04165070",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04165070",
"title": "KEYMAKER-U01 Substudy 01A: A Phase 1/2, Umbrella Study With Rolling Arms of Investigational Agents With Pembrolizumab With or Without Chemotherapy in Treatment-Naive Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2032-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991556",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06991556",
"title": "A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2032-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057402",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06057402",
"title": "ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2032-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807281",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06807281",
"title": "A Phase 3, Multicenter, Long-Term, Open Label Study Evaluating the Safety and Efficacy of Abrocitinib, With or Without Topical Medications Administered to Pediatric Participants Aged 2 Years and Older With Moderate-to-Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2032-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06692712",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06692712",
"title": "Intrathecal Administration of MELPIDA (AAV9/AP4M1) for Hereditary Spastic Paraplegia Type 50 (SPG50): a Phase 3, Open-Label Trial with Matched Prospective Concurrent Control Arm",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2032-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05143840",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05143840",
"title": "Asciminib as Initial Therapy With Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia Who do Not Achieve Optimal Response or a Deep Molecular Remission (ALERT CML)",
"has_exemption": false,
"start_date": "2022-04-22",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Augusta University",
"sponsor_slug": "augusta-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06073821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06073821",
"title": "A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2023-11-11",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788522",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06788522",
"title": "The Effects of Orexin Antagonism on Fear Extinction in PTSD",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2032-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780098",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06780098",
"title": "KEYMAKER-U01 Substudy 01I: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2032-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05521997",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05521997",
"title": "Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2032-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731907",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06731907",
"title": "KEYMAKER-U01 Substudy 01G: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab With or Without Platinum-based Chemotherapy in Treatment-Naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-30",
"completion_date": "2032-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022483",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07022483",
"title": "A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy With or Without Radiotherapy as Adjuvant Treatment for HER2-Expressing (IHC 3+/2+) Endometrial Cancer (DESTINY-Endometrial02/ GOG-3122/ ENGOT-en30/GINECO)",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2032-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06337318",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06337318",
"title": "Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-10-23",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649747",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06649747",
"title": "A Double-blind, Placebo-controlled, Multi-center Phase II Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral AFA-281 in Patients With Painful Lumbosacral Radiculopathy",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Afasci Inc",
"sponsor_slug": "afasci-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05295433",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05295433",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705",
"has_exemption": false,
"start_date": "2022-03-08",
"completion_date": "2032-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714085",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05714085",
"title": "A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2032-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06666322",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06666322",
"title": "Platform Trial For Cryptococcal Meningitis",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2032-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04665739",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04665739",
"title": "Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2023-02-03",
"completion_date": "2032-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04114136",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04114136",
"title": "A Phase II Clinical Trial of Anti-PD-1 mAb Therapy Alone or With Metabolic Modulators to Reverse Tumor Hypoxia and Immune Dysfunction in Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2020-09-14",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dan Zandberg",
"sponsor_slug": "dan-zandberg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04093349",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04093349",
"title": "Phase 1/2, Dose-escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of SPK-3006 in Adults With Late-onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-01",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics, Inc.",
"sponsor_slug": "spark-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05031897",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05031897",
"title": "A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05833763",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05833763",
"title": "An Open-label, Single-arm, Phase 2 Trial of GlOfitamab anD pIrtobrutinib (LOXo-305) in Patients With Mantle Cell Lymphoma and Prior Exposure to a BTK Inhibitor",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Australasian Leukaemia and Lymphoma Group",
"sponsor_slug": "australasian-leukaemia-and-lymphoma-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03761108",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03761108",
"title": "Phase 1/2 FIH Study of REGN5458 (Anti-BCMA x Anti-CD3 Bispecific Antibody) in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2019-01-23",
"completion_date": "2032-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140524",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06140524",
"title": "Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2032-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952504",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06952504",
"title": "A Phase 3 Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of Sacituzumab Tirumotecan in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-line Maintenance Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (TroFuse-033/GOG-3119/ENGOT-en29)",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2032-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05630053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05630053",
"title": "Randomized Controlled Trial to Compare Persona OsseoTi Keel Cementless TKA vs Persona Keel Cemented TKA",
"has_exemption": false,
"start_date": "2023-07-25",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06374459",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06374459",
"title": "A Phase Ib/II Trial of Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773910",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06773910",
"title": "An Open-label, Randomized Study of BMS-986489 (Atigotatug + Nivolumab Fixed-dose Combination) vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-stage Small-cell Lung Cancer (TIGOS-LS)",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07005154",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07005154",
"title": "A Phase 2, Open-label, Multi-cohort Study to Assess the Efficacy and Safety of ASP5541 in Participants With Advanced Prostate Cancer",
"has_exemption": false,
"start_date": "2025-06-19",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987449",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05987449",
"title": "A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2032-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05468359",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05468359",
"title": "ANGIO-A: Safety and Tolerability of Oral Cyclophosphamide and Sorafenib With Intravenous Bevacizumab With the Addition of Atezolizumab in Pediatric Solid Tumor Patients",
"has_exemption": false,
"start_date": "2022-11-07",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05425615",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05425615",
"title": "Probing Language Processes Using Transcranial Magnetic Stimulation",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494501",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06494501",
"title": "The Prevent Coronary Artery Disease Trial",
"has_exemption": false,
"start_date": "2024-09-12",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940739",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06940739",
"title": "A Phase 1/2, Open-label Study of a Modified Interleukin-2 Fusion Protein (IOV-3001) in Participants With Previously Treated, Unresectable or Metastatic Melanoma Who Will Receive Lifileucel",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445114",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06445114",
"title": "ULTRA-HPV Using Circulating Tumor DNA to Risk Adapt Post-operative Therapy for HPV Associated Oropharyngeal Cancer",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zachary Zumsteg",
"sponsor_slug": "zachary-zumsteg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06087263",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06087263",
"title": "Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991738",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06991738",
"title": "Phase 1/2, Open-Label Study of the Safety, Dosimetry and Efficacy of a 3-Dose Regimen of Escalating Doses of 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820957",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06820957",
"title": "Randomized Phase 2/3 Trial of Vincristine-Irinotecan-Regorafenib in Combination With Vincristine-Doxorubicin-Cyclophosphamide (VDC) and Ifosfamide-Etoposide (IE) in Patients With Newly Diagnosed Metastatic Ewing Sarcoma",
"has_exemption": false,
"start_date": "2025-09-13",
"completion_date": "2032-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06910124",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06910124",
"title": "Alpe d'Huez Study: A Parallel Two-Cohort Study of Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2032-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dickran Kazandjian, MD",
"sponsor_slug": "dickran-kazandjian-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05170204",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05170204",
"title": "A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2022-11-01",
"completion_date": "2032-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03579901",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03579901",
"title": "Study of the Safety and Effectiveness of the Motiva Implants® Silicone Gel-Filled Breast Implants SmoothSilk® in Subjects Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction, and Revision Surgery",
"has_exemption": false,
"start_date": "2018-04-06",
"completion_date": "2032-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Motiva USA LLC",
"sponsor_slug": "motiva-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05496959",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05496959",
"title": "177-Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (Lunar)",
"has_exemption": false,
"start_date": "2022-09-02",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06410534",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06410534",
"title": "A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991335",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06991335",
"title": "Deep Brain Stimulation (DBS) of the Ventral Capsule Ventral Striatum (VC/VS) for the Treatment of Apathy in Parkinson's Disease (PD)",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nora Vanegas",
"sponsor_slug": "nora-vanegas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04589845",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04589845",
"title": "Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial",
"has_exemption": false,
"start_date": "2021-01-18",
"completion_date": "2032-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04687020",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04687020",
"title": "Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NS Pharma, Inc.",
"sponsor_slug": "ns-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04910685",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04910685",
"title": "A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis",
"has_exemption": false,
"start_date": "2021-11-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Blueprint Medicines Corporation",
"sponsor_slug": "blueprint-medicines-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136559",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06136559",
"title": "A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06574126",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06574126",
"title": "Phase II Open-Label, Single Arm, Multicenter Study of Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma (GEM-CAR-HiRiSMM)",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05563948",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05563948",
"title": "Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05565105",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05565105",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Leukemia or Lymphoma",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Guenther Koehne",
"sponsor_slug": "guenther-koehne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05617625",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05617625",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Guenther Koehne",
"sponsor_slug": "guenther-koehne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05460000",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05460000",
"title": "A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy (N-Plus)",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2032-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "North Eastern German Society of Gynaecological Oncology",
"sponsor_slug": "north-eastern-german-society-of-gynaecological-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953778",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06953778",
"title": "CSP #2037S - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-S) Trial",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2032-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953726",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06953726",
"title": "CSP #2037T - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-T) Trial",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2032-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04576130",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04576130",
"title": "A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Who Receive Complete Revascularization",
"has_exemption": false,
"start_date": "2020-10-12",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rigshospitalet, Denmark",
"sponsor_slug": "rigshospitalet-denmark",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05508009",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05508009",
"title": "Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRαβ+ T-cell/CD19+ B-cell Depletion for Patients Who Will Receive a Kidney Transplant (KT) From the Same HSCT/KT Donor",
"has_exemption": false,
"start_date": "2023-01-10",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alice Bertaina",
"sponsor_slug": "alice-bertaina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06235697",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06235697",
"title": "Androgen Suppression Combined With Elective Nodal Irradiation and Dose Escalated Prostate Treatment: A Non-Inferiority, Phase III Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Brachytherapy Boost in Patients With Unfavourable Risk Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-25",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915025",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06915025",
"title": "A Randomized Phase 3 Trial Evaluating the Safety & Efficacy of IP IMNN-001 Administered in Combination w/ Standard Neoadjuvant & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2025-07-11",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Imunon",
"sponsor_slug": "imunon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015853",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07015853",
"title": "IIT2024-02-SHIAO-ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephen Shiao",
"sponsor_slug": "stephen-shiao",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04557462",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04557462",
"title": "A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2032-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05283720",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05283720",
"title": "Phase 1b/2, Open-Label Study to Evaluate Safety and Tolerability of Epcoritamab in Combination With Anti-Neoplastic Agents in Subjects With Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-06-14",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06215716",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06215716",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis",
"has_exemption": false,
"start_date": "2023-12-01",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akero Therapeutics, Inc",
"sponsor_slug": "akero-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06974786",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06974786",
"title": "Frontline T-cell Engager vs Autologous Stem Cell Transplant and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma (FASTER)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024706",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07024706",
"title": "The MAVRiC Study: A Phase II Study of Disease Risk Mutation Guided Finite Duration Acalabrutinib Plus Venetoclax for Relapse in CLL/SLL After First-line Finite Covalent BTKi Plus BCL2i Combination, With or Without Obinutuzumab",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06379789",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06379789",
"title": "A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2032-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05955508",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05955508",
"title": "Phase 2 Study of Linvoseltamab in Patients With Smoldering Multiple Myeloma at High Risk of Progression to Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2032-12-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05795140",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05795140",
"title": "A Multi-center, Single Arm, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Iptacopan in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Who Have Completed a Preceding Iptacopan Phase 3 Study in aHUS",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2032-12-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01306019",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01306019",
"title": "Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency",
"has_exemption": false,
"start_date": "2012-09-25",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03520660",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03520660",
"title": "Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents",
"has_exemption": false,
"start_date": "2018-10-19",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04423211",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04423211",
"title": "Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)",
"has_exemption": false,
"start_date": "2020-10-08",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04880876",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04880876",
"title": "A Phase 3, Long-term Safety Study of Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)",
"has_exemption": false,
"start_date": "2021-08-13",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04597359",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04597359",
"title": "A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers",
"has_exemption": false,
"start_date": "2021-10-05",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05659082",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05659082",
"title": "Cognition and Magnetic Resonance Imaging After Psychiatric Neurosurgery for Intractable Obsessive-Compulsive Disorder- Phase 2",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Butler Hospital",
"sponsor_slug": "butler-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06714604",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06714604",
"title": "Standard Versus Prolonged Neoadjuvant (Conversion) Chemotherapy to Prolong Survival of Patients With Borderline and Locally Advanced Pancreatic Cancer: a Phase III Randomized Controlled",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sahlgrenska University Hospital",
"sponsor_slug": "sahlgrenska-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05975593",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05975593",
"title": "MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)",
"has_exemption": false,
"start_date": "2024-01-11",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06325709",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06325709",
"title": "Phase 1/2 Trial of Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-linked Chronic Granulomatous Disease",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06477939",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06477939",
"title": "Phase III Randomized Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients to Evaluate Efficacy and Safety",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Cancerologie Strasbourg Europe",
"sponsor_slug": "institut-de-cancerologie-strasbourg-europe",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06849258",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06849258",
"title": "A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of The FloStent in Men Suffering From Benign Prostatic Hyperplasia Symptoms",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rivermark Medical",
"sponsor_slug": "rivermark-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06010030",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06010030",
"title": "A Randomized Clinical Trial of TDCS to Remediate Phonological Impairment in Aphasia",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052618",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06052618",
"title": "Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876142",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06876142",
"title": "A Phase 1b/2 Study of Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma (RRMM)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03003299",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03003299",
"title": "A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve",
"has_exemption": false,
"start_date": "2017-01-05",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06048159",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06048159",
"title": "TACS for the Recovery of Phonological STM After Stroke",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625034",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06625034",
"title": "Randomized Phase III Trial of Rapid-Plan Knowledge-Based Planning vs. Human-Driven Planning for Prostate Cancer Radiotherapy",
"has_exemption": false,
"start_date": "2025-02-02",
"completion_date": "2033-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465199",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06465199",
"title": "A Dose Escalation Study Using Difluoromethylornithine (DFMO) and AMXT-1501 Followed by a Randomized Controlled Trial of DFMO With or Without AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2033-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966700",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06966700",
"title": "A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2033-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05786066",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05786066",
"title": "The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929768",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05929768",
"title": "Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952803",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06952803",
"title": "A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients With BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (EvoPAR-Prostate02).",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007065",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07007065",
"title": "A Randomized, Controlled, Partially Masked, Phase 3b Study to Assess the Injection Burden, Efficacy, Safety, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) in a Real-World Context in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05705453",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05705453",
"title": "Epidural Stimulation After Neurologic Damage: Long-Term Outcomes",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2033-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730036",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05730036",
"title": "An Open-label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458; Anti- BCMA x Anti-CD3 Bispecific Antibody) Versus the Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPd), in Patients With Relapsed/Refractory Multiple Myeloma (LINKER-MM3)",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2033-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01742299",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01742299",
"title": "An Open Label, Multi-center Imatinib Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Imatinib Study and Are Judged by the Investigator to Benefit From Continued Imatinib Treatment",
"has_exemption": false,
"start_date": "2013-03-26",
"completion_date": "2033-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05505643",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05505643",
"title": "COOL-IT: Cryoablation vs Lumpectomy in T1 Breast Cancers: A Randomized Controlled Trial With Safety Lead-in",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01796795",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01796795",
"title": "A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.",
"has_exemption": false,
"start_date": "2030-09-30",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "G&E Herbal Biotechnology Co., LTD",
"sponsor_slug": "ge-herbal-biotechnology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899673",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05899673",
"title": "A Phase 3, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Fazirsiran in Participants With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2033-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06623422",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06623422",
"title": "A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy (INTerpath-009)",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2033-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128564",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06128564",
"title": "A Two-Part, Open-Label Systemic Gene Delivery Study to Evaluate the Safety and Expression of RO7494222 (SRP-9001) in Subjects Under the Age of Four With Duchenne Muscular Dystrophy",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2033-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06382272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06382272",
"title": "Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy",
"has_exemption": false,
"start_date": "2025-02-18",
"completion_date": "2033-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02339571",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02339571",
"title": "Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma",
"has_exemption": false,
"start_date": "2015-11-23",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05257083",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05257083",
"title": "A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting European Myeloma Network",
"sponsor_slug": "stichting-european-myeloma-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236724",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06236724",
"title": "Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2033-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060807",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07060807",
"title": "An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physician's Choice in Hormone Receptor-positive, HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer (HERTHENA-Breast04)",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2033-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05803941",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05803941",
"title": "A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Participants With Prostate Cancer",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2033-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04510597",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04510597",
"title": "Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)",
"has_exemption": false,
"start_date": "2021-03-08",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04984291",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04984291",
"title": "Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2021-07-28",
"completion_date": "2033-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01736592",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01736592",
"title": "An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration",
"has_exemption": false,
"start_date": "2012-12-14",
"completion_date": "2033-08-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06055712",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06055712",
"title": "Antibiotic Prophylaxis in Pediatric Open Fractures",
"has_exemption": false,
"start_date": "2023-09-11",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Louis University",
"sponsor_slug": "st-louis-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07080905",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07080905",
"title": "Phase 3, Open-label, Single-dose, Multicenter Study Investigating Efficacy, Safety, and Tolerability of CSL222 (Etranacogene Dezaparvovec) Administered to Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2033-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04636190",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04636190",
"title": "A Retrospectively Enrolled and Prospectively Followed, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon All-Polyethylene Tibia",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05994235",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05994235",
"title": "A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-11-01",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06339320",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06339320",
"title": "Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05660408",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05660408",
"title": "RNA PRIME - RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03755739",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03755739",
"title": "A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2018-11-01",
"completion_date": "2033-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06368817",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06368817",
"title": "A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2033-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669247",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06669247",
"title": "A First-in-Human (FIH) Phase 1/2 Study to Assess Safety, Tolerability, and Preliminary Anti-Tumor Activity of REGN7945, an Anti-CD38 x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Linvoseltamab, an Anti-BCMA x Anti-CD3 Bispecific Monoclonal Antibody, in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-12-11",
"completion_date": "2033-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04742634",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04742634",
"title": "A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant",
"has_exemption": false,
"start_date": "2022-05-12",
"completion_date": "2033-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07058077",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07058077",
"title": "An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants With Heterozygous Familial Hypercholesterolemia",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2033-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05642195",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05642195",
"title": "Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2033-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04513717",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04513717",
"title": "Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)",
"has_exemption": false,
"start_date": "2021-01-21",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04754087",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04754087",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the G7 Acetabular System With Vivacit-E and Longevity Highly Crosslinked Polyethylene (HXLPE) Liners & Instrumentation",
"has_exemption": false,
"start_date": "2021-07-07",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05951205",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05951205",
"title": "A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects With Severe Sickle Cell Disease, βS/βC Genotype",
"has_exemption": false,
"start_date": "2027-07-31",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02106988",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02106988",
"title": "Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Patients With Stage I/II Nasal NK Cell Lymphoma",
"has_exemption": false,
"start_date": "2015-01-16",
"completion_date": "2034-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06312137",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06312137",
"title": "A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Followed by Surgery",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2034-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06337032",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06337032",
"title": "An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments",
"has_exemption": false,
"start_date": "2024-08-27",
"completion_date": "2034-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05552157",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05552157",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-11-22",
"completion_date": "2034-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06647498",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06647498",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-11-22",
"completion_date": "2034-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05144191",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05144191",
"title": "Insignia™ Hip Stem Outcomes Study - A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia™ Hip Stem for Total Hip Replacement Surgery",
"has_exemption": false,
"start_date": "2022-02-07",
"completion_date": "2034-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559540",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06559540",
"title": "SWIFT RT: Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer",
"has_exemption": false,
"start_date": "2024-08-27",
"completion_date": "2034-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264388",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06264388",
"title": "A Biomarker-Guided Phase 2 Study of DB107-RRV (Retroviral Replicating Vector) Combined With DB107-Flucytosine Extended-Release Tablets in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2034-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ashish Shah",
"sponsor_slug": "ashish-shah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06400342",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06400342",
"title": "Randomized Evaluation of Valve-In-Valve Versus Explantation for Failed TAVR (REVIVE-TAVR)",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2034-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04817969",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04817969",
"title": "Persona® Ti-Nidium® Personalized Total Knee System A Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data Using the Persona Ti-Nidium Total Knee System and Instrumentation",
"has_exemption": false,
"start_date": "2021-06-01",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06289673",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06289673",
"title": "INITIALL: Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma",
"has_exemption": false,
"start_date": "2024-12-26",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06239272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06239272",
"title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",
"has_exemption": false,
"start_date": "2024-03-27",
"completion_date": "2034-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06348134",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06348134",
"title": "Assessing the Efficacy and Safety of Optimal Neoadjuvant to Adjuvant Anti-HER2- Based Therapy in Nigerian Women With HER2+ Breast Cancer",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2034-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071519",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07071519",
"title": "A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Open-Label Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2034-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05907759",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05907759",
"title": "A Phase II Study of Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2034-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06569082",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06569082",
"title": "CD34+ Selected Donor Cell Boost for Management of Poor Graft Function or Primary or Secondary Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2034-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926634",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06926634",
"title": "Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2034-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06085742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06085742",
"title": "BRE-08: A Phase II Study of an All-Oral Adjuvant Chemotherapy Regimen of Cyclophosphamide, Methotrexate, and Capecitabine (CMC) for Early-Stage Breast Cancer",
"has_exemption": false,
"start_date": "2023-11-22",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977036",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05977036",
"title": "BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023641",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06023641",
"title": "A Protocol for the Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2034-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06351631",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06351631",
"title": "A Multicenter, Open-Label, Extension Study Evaluating the Safety and Efficacy of Bomedemstat for the Treatment of Participants Enrolled in a Prior Bomedemstat Clinical Study",
"has_exemption": false,
"start_date": "2024-05-23",
"completion_date": "2034-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764095",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06764095",
"title": "CAST-AI: Cystectomy After Systemic Therapy With ADC and Immunotherapy",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06851767",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06851767",
"title": "Phase 1/2 Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy",
"has_exemption": false,
"start_date": "2025-05-09",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307146",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05307146",
"title": "Study of Brain Activity in Candidates for Epilepsy Surgery",
"has_exemption": false,
"start_date": "2013-12-18",
"completion_date": "2035-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06820736",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06820736",
"title": "A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2035-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Twin Cities Spine Center",
"sponsor_slug": "twin-cities-spine-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06826612",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06826612",
"title": "A Phase 1/2, Randomized, Sequential, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of a One-Time, Bilateral, Intraparenchymal Infusion of SPK-10001 Into the Caudate and Putamen in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2035-01-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics, Inc.",
"sponsor_slug": "spark-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05947851",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05947851",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib (MK-1026) Plus Venetoclax Versus Venetoclax Plus Rituximab in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least 1 Prior Therapy (BELLWAVE-010)",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2035-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931301",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06931301",
"title": "Effect of Hyperbaric Oxygen Therapy on Osteonecrosis of the Femoral Head When Combined With 3D Navigated Core Decompression With Bone Marrow Aspirate Concentrate",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2035-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412497",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06412497",
"title": "MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2035-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06037356",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06037356",
"title": "Prostatic Urethral Lift Versus Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients With Urinary Retention",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2035-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Queen Mary Hospital, Hong Kong",
"sponsor_slug": "queen-mary-hospital-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02177721",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02177721",
"title": "A Field Study to Evaluate the Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2035-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emergent BioSolutions",
"sponsor_slug": "emergent-biosolutions",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04731077",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04731077",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete™ Femoral Stem (Implants and Instrumentation)",
"has_exemption": false,
"start_date": "2021-09-27",
"completion_date": "2035-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06728072",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06728072",
"title": "Pilot Study Evaluating Microbiome Modulation Therapy (MBMT) With Ciprofloxacin, Metronidazole, and Aspirin in Addition to Standard of Care Chemotherapy in Patients Undergoing First-Line Therapy for Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2035-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05535166",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05535166",
"title": "SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2035-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01654133",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01654133",
"title": "Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts",
"has_exemption": false,
"start_date": "2012-07-31",
"completion_date": "2035-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07005024",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07005024",
"title": "A Comparison of Anticoagulant Dosing Strategies to Reduce VTE and Mortality in Cancer Outpatients: A Randomized, Pragmatic Trial",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2035-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Vermont",
"sponsor_slug": "university-of-vermont",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06995053",
"title": "Image-Guidance With Triggered Beam Hold To Implanted Fiducial Markers or Hypersight for Stereotactic Body Radiotherapy for Prostate Cancer (ILLUSION)",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2035-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07072585",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07072585",
"title": "A Phase 2/3 Randomized Trial Investigating Daratumumab on a Modified Augmented BFM (aBFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2035-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053436",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07053436",
"title": "MMRC Horizon Two: A Phase II Randomized Adaptive Platform Trial Integrating Novel Therapies in High-Risk-Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2035-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Multiple Myeloma Research Consortium",
"sponsor_slug": "multiple-myeloma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03841617",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03841617",
"title": "The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer",
"has_exemption": false,
"start_date": "2019-07-29",
"completion_date": "2035-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828511",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05828511",
"title": "Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2035-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04699591",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04699591",
"title": "Compassionate Use of Domperidone for Refractory Gastroparesis",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Mercy Hospital Kansas City",
"sponsor_slug": "childrens-mercy-hospital-kansas-city",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02469662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02469662",
"title": "Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04042025",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04042025",
"title": "A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101",
"has_exemption": false,
"start_date": "2020-02-10",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Gene Therapies",
"sponsor_slug": "novartis-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}